Elizabeth de Somer, chief executive of pharma trade group Medicines Australia, has echoed calls by the Prime Minister Scott Morrison, for Australians to stop stockpiling medicine during the ongoing COVID pandemic.
“It is imperative, as an industry and as a nation, for us to employ every public health strategy and commit every effort to focus on COVID19 and help to protect and treat the community,” said Ms de Somer.
“Member companies of Medicines Australia and their global counterparts – are working tirelessly to eradicate COVID19 – to increases diagnostic capability, develop a vaccine and find effective treatments. We hope this focus will generate success in the coming months. Each step forward will be shared.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze